New approaches in the treatment of asthma

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Immunology and Cell Biology

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1440-1711.2001.00987.xPMID 11264710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody humanization: a case of the 'Emperor's new clothes'?

  2000cited by this paper
• Clinical trials of antibody therapy.

  2000cited by this paper
• Integrated Signals Between IL-13, IL-4, and IL-5 Regulate Airways Hyperreactivity

  2000cited by this paper
• Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist.

  2000cited by this paper
• Allergen‐induced airway inflammation and bronchial responsiveness in interleukin‐5 receptor α chain‐deficient mice

  2000cited by this paper
• CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.

  2000cited by this paper
• Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors.

  1999cited by this paper
• Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

  1999cited by this paper
• Simultaneous Antagonism of Interleukin-5, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-3 Stimulation of Human Eosinophils by Targetting the Common Cytokine Binding Site of Their Receptors

  1999cited by this paper
• The alliance of genes and environment in asthma and allergy

  1999cited by this paper
• TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma.

  1999cited by this paper
• BONE MARROW IN ALLERGIC DISEASE : THE ROLE OF INTERLEUKIN-5 AS AN EOSINOPHILOPOIETIC FACTOR

  1999cited by this paper
• Mechanism of Activation of the GM‐CSF, IL‐3, and IL‐5 Family of Receptors

  1998cited by this paper
• The biological consequences of excess GM-CSF levels in transgenic mice also lacking high-affinity receptors for GM-CSF

  1998cited by this paper
• Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways.

  1998cited by this paper
• Interleukin-13: central mediator of allergic asthma

  1998cited by this paper
• Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation

  1998cited by this paper
• Requirement for IL-13 independently of IL-4 in experimental asthma

  1998cited by this paper
• Functional analysis of mature hematopoietic cells from mice lacking the betac chain of the granulocyte-macrophage colony-stimulating factor receptor.

  1998cited by this paper
• Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee.

  1998cited by this paper
• Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin.

  1998cited by this paper
• Functional Analysis of Mature Hematopoietic Cells From Mice Lacking the βc Chain of the Granulocyte-Macrophage Colony-Stimulating Factor Receptor

  1998cited by this paper
• Interleukin-13: central mediator of allergic asthma.

  1998cited by this paper
• Requirement for IL-13 independently of IL-4 in experimental asthma.

  1998cited by this paper
• Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.

  1997cited by this paper
• Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization.

  1997cited by this paper
• An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils

  1997cited by this paper
• Mechanisms of human eosinophil survival and apoptosis

  1997cited by this paper
• Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines.

  1997cited by this paper
• Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.

  1997cited by this paper
• Soluble cytokine receptors.

  1996cited by this paper
• Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

  1996cited by this paper
• Biology of interleukin‐5 and its relevance to allergic disease

  1996cited by this paper
• A Single Tyrosine Residue in the Membrane-proximal Domain of the Granulocyte-Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 Receptor Common β-Chain Is Necessary and Sufficient for High Affinity Binding and Signaling by All Three Ligands*

  1996cited by this paper
• Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.

  1996cited by this paper
• Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

  1995cited by this paper
• Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo

  1995cited by this paper
• Effects of an antibody to interleukin-5 in a monkey model of asthma.

  1995cited by this paper
• Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.

  1995cited by this paper
• Specific human granulocyte-macrophage colony-stimulating factor antagonists.

  1994cited by this paper
• Three residues in the common beta chain of the human GM‐CSF, IL‐3 and IL‐5 receptors are essential for GM‐CSF and IL‐5 but not IL‐3 high affinity binding and interact with Glu21 of GM‐CSF.

  1994cited by this paper
• Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs.

  1993cited by this paper
• Interleukin-5, eosinophils, and disease.

  1992cited by this paper
• Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.

  1992cited by this paper
• A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

  1991cited by this paper
• Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization.

  1991cited by this paper
• Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.

  1991cited by this paper
• A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.

  1991cited by this paper
• Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

  1989cited by this paper

• Pharmacological evaluation of cellular and molecular mechanism of Anti-Inflammatory and Immunomodulatory effects of traditional herbal drug extract of Hedychium spicatum in Experimental Models of Bronchial Asthma

  2024cites this paper
• MicroRNAs in Asthma and COPD; from biomarkers to regulators of disease pathogenesis

  2022cites this paper
• Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation

  2019cites this paper
• Experimental studies to evaluate the immunomodulatory and anti-inflammatory potential of optimized polyherbal preparations in experimental model of asthma

  2018cites this paper
• Biological studies on the effect of estrogen on experimentally induced asthma in mice

  2016cites this paper
• Protéines de liaison à cd131 et leurs utilisations

  2016cites this paper
• Cellular and molecular mechanisms of action of polyherbal preparation UNIM-352 in experimental models of bronchial asthma.

  2015cites this paper
• Intranasal curcumin attenuates airway remodeling in murine model of chronic asthma.

  2014cites this paper
• HISTOLOGICAL STUDY OF THE EFFECT OF ESTROGEN ON ASTHMATIC MALE MICE

  2013influential citation
• The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors.

  2013cites this paper
• Anti-Inflammatory and Immune Regulatory Effects of Salvia officinalis Extract on OVA-induced Asthma in Mice

  2012cites this paper
• New Advances and Potential Therapies for the Treatment of Asthma

  2012cites this paper
• Leukotriene A4 Hydrolase – An Evolving Therapeutic Target

  2012cites this paper
• Protective Effects of Mentha haplocalyx Ethanol Extract (MH) in a Mouse Model of Allergic Asthma

  2011cites this paper
• COMPARATIVE STUDY BETWEEN ORCHIDECTOMY ALONE AND ORCHIDECTOMY WITH HORMONAL THERAPY (COMBINED ANDROGEN BLOCKADE) FOR PATIENTS WITH ADVANCED CARCINOMA OF THE PROSTATE

  2010cites this paper
• ROLE OF MALVA PARVIFLORA FLOWER EXTRACT ON ALLERGEN-INDUCED EOSINOPHILIA IN MICE -

  2009influential citation
• Role of arginine metabolism in immunity and immunopathology.

  2008cites this paper
• Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina

  2007cites this paper
• Abundant eosinophil infiltration in a neurofibroma.

  2007cites this paper
• Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice

  2007influential citation
• 308 Peptide-based approaches to treat asthma , arthritis , other autoimmune diseases and pathologies of the central nervous system

  2005cites this paper
• Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system.

  2005cites this paper
• The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease.

  2005cites this paper
• Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.

  2005cites this paper
• Cytokines in Mycoplasma pneumoniae infections.

  2004cites this paper
• New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease

  2004cites this paper
• Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.

  2004cites this paper
• Regulation of haematopoiesis by growth factors – emerging insights and therapies

  2004cites this paper
• The Role of Human Mast Cell-Derived Cytokines in Eosinophil Biology

  2004cites this paper
• Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.

  2003cites this paper
• Effects of histamine on Th1/Th2 cytokine balance.

  2003cites this paper
• Novel therapies for the treatment of inflammatory airway disease

  2003cites this paper
• Development of CD4+ T cell lines that suppress an antigen‐specific immune response in vivo

  2003cites this paper
• Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma

  2002cites this paper
• Non-cancer therapeutic antibodies

  2002cites this paper
• Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.

  2002cites this paper
• Allergy and Hypersensitivity

  2001cites this paper
• Granulocyte Adhesion to Matrix Proteins and the Effect on the Release of Granule Proteins : Development of a Simple Method and its Application in Experimental and Clinical Studies

  2001cites this paper
• Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice

  1999cites this paper